- Home
- MLSS vs ESLA Comparison
MLSS vs ESLA Comparison
Compare MLSS & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MLSS | ESLA |
|---|---|---|
| Founded | 1989 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.2M | 32.5M |
| IPO Year | 1996 | 2021 |
Fundamental Metrics
Financial Performance| Metric | MLSS | ESLA |
|---|---|---|
| Price | $0.30 | $0.50 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $1.25 | N/A |
| AVG Volume (30 Days) | 97.5K | ★ 4.2M |
| Earning Date | 11-12-2026 | 11-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $8,973,982.00 | N/A |
| Revenue This Year | $11.14 | N/A |
| Revenue Next Year | $13.80 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 3.99 | N/A |
| 52 Week Low | $0.22 | $0.24 |
| 52 Week High | $0.58 | $2.33 |
Technical Indicators
Market Signals| Indicator | MLSS | ESLA |
|---|---|---|
| Relative Strength Index (RSI) | 42.11 | 47.20 |
| Support Level | $0.30 | $0.34 |
| Resistance Level | $0.31 | $0.51 |
| Average True Range (ATR) | 0.03 | 0.16 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 23.08 | 23.23 |
Price Performance
Historical ComparisonAbout MLSS Milestone Scientific Inc.
Milestone Scientific Inc develops and commercializes proprietary computer-controlled drug delivery systems designed to enhance the safety, precision, and patient experience associated with subcutaneous injections and fluid aspiration procedures. The company's core technology platform, Dynamic Pressure Sensing (DPS) Technology, controls flow rate and measures pressure at the needle tip in real time. DPS Technology is incorporated into both the company's dental and medical products and supports clinical applications, including local anesthesia delivery, epidural space identification in regional anesthesia procedures, and intra-articular joint injections. It operates in two segments: Dental, which markets and sells its dental products, and Medical, markets and sells its medical products.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.